Lucknow: In a step towards strengthening its position as a pharmaceutical manufacturing hub, the UP State Industrial Development Authority (UPSIDA) signed a strategic MoU with the Jawaharlal Nehru Port Authority (JNPA).The agreement aims to transform the upcoming Lalitpur Pharma Park into a globally connected export hub by integrating it with multimodal logistics networks. The MoU, signed by UPSIDA CEO Vijay Kiran Anand and JNPA chairman Gaurav Dayal, seeks to provide seamless connectivity between industrial regions in North India and international markets. Officials said the partnership would enable faster, safer and cost-effective movement of pharmaceutical goods, boosting UP’s export capabilities. A key feature of the initiative is the planned linkage of Lalitpur Pharma Park to both the Western and Eastern Dedicated Freight Corridors through the Dadri–Khurja rail link. This connectivity is expected to significantly reduce transit time and logistics costs, making the park more attractive to investors and exporters. Integration with JNPA will provide access to over 200 international ports, offering pharmaceutical manufacturers in UP direct entry into global supply chains. “The project reflects CM Yogi Adityanath’s vision of making Uttar Pradesh a leader in pharmaceutical manufacturing and healthcare services,” said Vijay Kiran Anand in a statement.
